Stay updated on Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page.

Latest updates to the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no substantive changes to study details, eligibility, or results sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedRemoved the banner about government funding lapse and NIH operating status from the page; no changes to study details, eligibility criteria, or other content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study record now shows termination due to lack of efficacy at the 5 mg dose and includes the Results First Posted date (2021-05-07).SummaryDifference0.2%

- Check64 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

- Check71 days agoChange DetectedUpdated version to v3.1.0 and removed several drug-safety topic items (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while retaining an older revision tag v3.0.2 in deletions, indicating a reorganization of content and scope.SummaryDifference0.3%

- Check85 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1); the Back to Top link has been removed.SummaryDifference0.2%

Stay in the know with updates to Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page.